Cargando…

Non-pharmaceutical interventions and the emergence of pathogen variants

Non-pharmaceutical interventions (NPIs), such as social distancing and contact tracing, are important public health measures that can reduce pathogen transmission. In addition to playing a crucial role in suppressing transmission, NPIs influence pathogen evolution by mediating mutation supply, restr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashby, Ben, Smith, Cameron A, Thompson, Robin N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052376/
https://www.ncbi.nlm.nih.gov/pubmed/37007165
http://dx.doi.org/10.1093/emph/eoac043
_version_ 1785015146549084160
author Ashby, Ben
Smith, Cameron A
Thompson, Robin N
author_facet Ashby, Ben
Smith, Cameron A
Thompson, Robin N
author_sort Ashby, Ben
collection PubMed
description Non-pharmaceutical interventions (NPIs), such as social distancing and contact tracing, are important public health measures that can reduce pathogen transmission. In addition to playing a crucial role in suppressing transmission, NPIs influence pathogen evolution by mediating mutation supply, restricting the availability of susceptible hosts, and altering the strength of selection for novel variants. Yet it is unclear how NPIs might affect the emergence of novel variants that are able to escape pre-existing immunity (partially or fully), are more transmissible or cause greater mortality. We analyse a stochastic two-strain epidemiological model to determine how the strength and timing of NPIs affect the emergence of variants with similar or contrasting life-history characteristics to the wild type. We show that, while stronger and timelier NPIs generally reduce the likelihood of variant emergence, it is possible for more transmissible variants with high cross-immunity to have a greater probability of emerging at intermediate levels of NPIs. This is because intermediate levels of NPIs allow an epidemic of the wild type that is neither too small (facilitating high mutation supply), nor too large (leaving a large pool of susceptible hosts), to prevent a novel variant from becoming established in the host population. However, since one cannot predict the characteristics of a variant, the best strategy to prevent emergence is likely to be an implementation of strong, timely NPIs.
format Online
Article
Text
id pubmed-10052376
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-100523762023-03-30 Non-pharmaceutical interventions and the emergence of pathogen variants Ashby, Ben Smith, Cameron A Thompson, Robin N Evol Med Public Health Original Research Article Non-pharmaceutical interventions (NPIs), such as social distancing and contact tracing, are important public health measures that can reduce pathogen transmission. In addition to playing a crucial role in suppressing transmission, NPIs influence pathogen evolution by mediating mutation supply, restricting the availability of susceptible hosts, and altering the strength of selection for novel variants. Yet it is unclear how NPIs might affect the emergence of novel variants that are able to escape pre-existing immunity (partially or fully), are more transmissible or cause greater mortality. We analyse a stochastic two-strain epidemiological model to determine how the strength and timing of NPIs affect the emergence of variants with similar or contrasting life-history characteristics to the wild type. We show that, while stronger and timelier NPIs generally reduce the likelihood of variant emergence, it is possible for more transmissible variants with high cross-immunity to have a greater probability of emerging at intermediate levels of NPIs. This is because intermediate levels of NPIs allow an epidemic of the wild type that is neither too small (facilitating high mutation supply), nor too large (leaving a large pool of susceptible hosts), to prevent a novel variant from becoming established in the host population. However, since one cannot predict the characteristics of a variant, the best strategy to prevent emergence is likely to be an implementation of strong, timely NPIs. Oxford University Press 2022-12-19 /pmc/articles/PMC10052376/ /pubmed/37007165 http://dx.doi.org/10.1093/emph/eoac043 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Ashby, Ben
Smith, Cameron A
Thompson, Robin N
Non-pharmaceutical interventions and the emergence of pathogen variants
title Non-pharmaceutical interventions and the emergence of pathogen variants
title_full Non-pharmaceutical interventions and the emergence of pathogen variants
title_fullStr Non-pharmaceutical interventions and the emergence of pathogen variants
title_full_unstemmed Non-pharmaceutical interventions and the emergence of pathogen variants
title_short Non-pharmaceutical interventions and the emergence of pathogen variants
title_sort non-pharmaceutical interventions and the emergence of pathogen variants
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052376/
https://www.ncbi.nlm.nih.gov/pubmed/37007165
http://dx.doi.org/10.1093/emph/eoac043
work_keys_str_mv AT ashbyben nonpharmaceuticalinterventionsandtheemergenceofpathogenvariants
AT smithcamerona nonpharmaceuticalinterventionsandtheemergenceofpathogenvariants
AT thompsonrobinn nonpharmaceuticalinterventionsandtheemergenceofpathogenvariants